Guerbet to participate at the COGI Congress
Guerbet will be Silver Sponsor at the 27th World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). The COGI Congress aims to provide a forum of the highest standard for scientific, educational and social exchange between professionals involved in Women’s Health, and to continue in its mission to promote research and education and to […]
Guerbet to participate in the 75th annual meeting of the ASRM
Guerbet will participate in the 75th annual meeting of the American Society for Reproductive Medicine (ASRM). This year’s ASRM Scientific Congress & Expo theme is “Celebrating 75 Years of History and Innovation” in keeping with their anniversary and the critical role of ASRM in focusing on the many innovations in reproductive medicine. Guerbet teams will be […]
ASPIRE 2019, Guerbet involved in Women’s Healthcare!
A major event, the ASPIRE congress brings together international health professionals with interest in reproductive medicine and fertility Organization of a symposium “Current & Future Trends of Hysterosalpingography (HSG) in Clinical Practice” on May 4 from 15:00 to 16:30 The 9th Congress of the Asia Pacific Initiative of Reproduction (ASPIRE 2019) will take place at […]
Guerbet teams will attend IFFS 2019!
The 2019 edition of the IFFS congress (International Federation of Fertility Societies) will be held in Shanghai, China from April 11th to 14th. IFFS stimulates basic and clinical research, disseminates education, and encourages superior clinical care of patients in infertility and reproductive medicine worldwide. Guerbet teams warmly invite healthcare professionals to know more about its […]
Guerbet teams will attend ESHRE 2018!
The 2018 edition of the ESHRE congress will be held In Barcelona, Spain from July 1st to 4th. The European Society of Human Reproduction and Embryology is the annual meeting to promote interest in reproductive biology and medicine. It does this through facilitating research and embryology to the general public, scientists, clinicians and patient associations. […]
H2Oil Trial using Lipiodol® UF for hysterosalpingography published in the New England Journal of Medicine
Guerbet announced that a clinical study, published today in the New England Journal of Medicine and presented at the 13th World Congress on Endometriosis in Vancouver, Canada, shows interesting clinical data about hysterosalpingography examination with Lipiodol® Ultra-Fluide. This content, intended for medical journalists, is available on l’article www.guerbet.com/en/media/press-releases/h2oil-randomized-controlled-trial-using-lipiodolr-ultra-fluide in the Media section.